ARTICLE | Clinical News
OncorMed regulatory update
June 15, 1998 7:00 AM UTC
ONM received U.S. Patent No. 5,756,294 covering a new mutation in the BRCA1 gene, which is associated with breast, ovarian and prostate cancer. ONM's patents covering diagnostic services relating to ...